New Abu Dhabi Clinical Trials Using AI to Have 'Massive' Impact on Health Care
OVERVIEWAbu Dhabi has launched clinical trials incorporating artificial intelligence to accelerate patient matching, trial enrollment, and real-world evidence generation, with health authorities predicting a "massive" impact on regional healthcare delivery and clinical research infrastructure. The trials leverage AI for patient phenotyping, predictive enrollment modeling, and real-time outcome tracking across multiple health systems and research institutions. The initiative positions Abu Dhabi as a leader in AI-enabled clinical research infrastructure and reflects broader Middle Eastern investment in healthcare AI and precision medicine platforms. The Abu Dhabi initiative demonstrates how regions outside the United States are building large-scale clinical AI infrastructure that may eventually influence global standards for AI-enabled clinical trials. Success in these trials could establish new models for accelerated patient enrollment, real-world evidence generation, and AI-guided precision medicine that influence international regulatory frameworks. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.